Very early onset inflammatory bowel disease was virtually unheard of just a decade ago. Today, a variety of personalized therapies exist, and potential curative gene therapies are on the horizon.

Continued surveillance after pancreatic solid pseudopapillary tumor and pancreatic insufficiency is important – even after treatment.

When rumination and gastroparesis collide in patients at Children’s Hospital of Philadelphia, a personalized treatment plan is developed.

Two recent studies show dupilumab improves eosinophilic esophagitis symptoms and pathology for adolescents and young adults.

Case: Langston is a 12-year-old with sickle cell disease whom you have followed in your practice since infancy.

Avery, a 5-year-old male, presents to the pediatrician for his well-child visit. His parents report that he is growing and developing well, but that they are concerned about recurrent nosebleeds that are happening most nights over the past week.

Researchers from CHOP and Penn are working to perfect 3D models of GI disease and create more personalized treatments for patients.

Fall 2022 saw the loss of two more CHOP luminaries as Ralph Wetmore, MD, former Chief of Otolaryngology, and Audrey Evans, MD, former Chief of Oncology, died in September.

Sickle cell disease (SCD) is the most common inherited blood disorder worldwide; with patients experiencing acute or chronic pain, and increased risk of bacterial infections, organ damage, and stroke.

Welcome back to the annual Chief Residents update column. Our residents have been working so hard during the pandemic and now the unprecedented fall viral surge.